Cell surface proteins that might represent promising candidates for targeting GBM and GS cells include Cathepsin D, CD99, EMMPRIN/CD147, Intβ1, the Galectins of the subfamily 3, and N-cadherin, all of which appeared rather independent of the stemness state. The gene discussed is CD99; the disease is glioblastoma.